NCT06652438 2025-04-04Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AMLStichting Hemato-Oncologie voor Volwassenen NederlandPhase 3 Recruiting415 enrolled